GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Granules India Ltd (NSE:GRANULES) » Definitions » Price-to-Free-Cash-Flow

Granules India (NSE:GRANULES) Price-to-Free-Cash-Flow : N/A (As of May. 24, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Granules India Price-to-Free-Cash-Flow?

As of today (2024-05-24), Granules India's share price is ₹429.45. Granules India's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00. Hence, Granules India's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Granules India's Price-to-Free-Cash-Flow or its related term are showing as below:

NSE:GRANULES' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0   Med: 4.27   Max: 176.87
Current: 176.87

During the past 13 years, Granules India's highest Price-to-Free-Cash-Flow Ratio was 176.87. The lowest was 0.00. And the median was 4.27.

NSE:GRANULES's Price-to-Free-Cash-Flow is ranked worse than
91.6% of 512 companies
in the Drug Manufacturers industry
Industry Median: 23.57 vs NSE:GRANULES: 176.87

Granules India's Free Cash Flow per Share for the three months ended in Mar. 2024 was ₹0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ₹0.00.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Granules India was -81.80% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -27.80% per year.

During the past 13 years, Granules India's highest 3-Year average Free Cash Flow per Share Growth Rate was 111.30% per year. The lowest was -57.70% per year. And the median was 7.05% per year.


Granules India Price-to-Free-Cash-Flow Historical Data

The historical data trend for Granules India's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Granules India Price-to-Free-Cash-Flow Chart

Granules India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.56 47.11 - 21.80 177.15

Granules India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.80 - - - 177.15

Competitive Comparison of Granules India's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Granules India's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Granules India's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Granules India's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Granules India's Price-to-Free-Cash-Flow falls into.



Granules India Price-to-Free-Cash-Flow Calculation

Granules India's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=429.45/0
=N/A

Granules India's Share Price of today is ₹429.45.
Granules India's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Granules India  (NSE:GRANULES) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Granules India Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Granules India's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Granules India (NSE:GRANULES) Business Description

Traded in Other Exchanges
Address
3rd Block, My Home Hub, 2nd Floor, Madhapur, Hyderabad, TG, IND, 500 081
Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages. Its business is organized into three areas; the Core business which comprises core molecules such as Paracetamol, Ibuprofen, Metformin, Guaifenesin, and Methocarbamol; the Emerging business that focuses on manufacturing APIs and the US Generics. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and Rest of World.

Granules India (NSE:GRANULES) Headlines

No Headlines